2024: Tromboz, Gemostaz i Reologiya, Nr. 1 | Tromboz, Gemostaz I Reologiya

Review

Alexei V. Muravyov, Irina A. Tikhomirova, Alexander V. Priezzhev, Andrei E. Lugovtsov

4-13

Blood rheology: mechanisms of change: 578.834:616.24-002.6

Dmitrii A. Evstratov, Pavel A. Zharkov, Alexander G. Rumyantsev

14-20

Prognostic risks of venous thrombosis in children: 616.151.5

Original papers

Natalia Yu. Khorkova, Tatiana P. Gizatulina, Elena A. Gorbatenko, Alfira V. Belokurova, Anna V. Zabytova

21-29

The role of thrombophilia gene polymorphisms in patients with non-valvular atrial fibrillation and left atrial appendage thrombosis: 616.12-008.313.2:616.125.2

Dmitry S. Pokhabov, Evgeny A. Shestakov, Oksana V. Fedyk, Eugene B. Zhiburt

30-36

Hemoglobin concentration and transfusion of ABO‐incompatible platelets: 616.411-003.971

Irina A. Sokolova, Vladimir B. Koshelev, Anastasia A. Fabrichnova, Alexey A. Glazkov, Yulia A. Kovaleva, Alexander A. Shakhnazarov

37-48

Abnormal erythrocyte aggregation in quiescent and flowing blood: 612.117

Alexander A. Spasov, Aida F. Kucheryavenko, Viktor S. Sirotenko, Ksenija A. Gaidukova, Georgy M. Uskov

49-56

Antiplatelet effects of umifenovir in hypercytokinemia: 615.151.55:547.592

Alexey S. Petrikov, Igor A. Suchkov, Eugene V. Roitman, Vitaly N. Shevchenko, Roman I. Svistula, Artem A. Chobanyan

57-70

Primary prevention of moderate- and high-risk venous thromboembolism in surgical patients with anterior abdominal wall hernias: 617-089:616-005.6:616.151.511

Alexey V. Lyanguzov, Alexander S. Luchinin, Olga Yu. Sergunina, Sergey V. Ignatyev, Andrey Yu. Bulanov, Natalia V. Minaeva

71-78

Clinical significance of screening coagulation tests in blood cancer patients with sepsis: 616.15-008.1:616.15-07

Nadezhda I. Zozulya, Svetlana Yu. Mamleeva, Nikolay V. Andreev, Oksana S. Dimitrieva, Elena A. Likhacheva, Elena V. Yakovleva, Olga I. Yastrubinetskaya

79-84

Achieving optimal blood coagulation factor VIII activity with a pharmacokinetic approach to choosing prevention in patients with hemophilia A: 616.151.514-056.7

Arkadiy L. Vertkin

85-95

Results of an open-label randomized crossover comparative study of the safety, pharmacodynamics and pharmacokinetics of romiplostim in healthy volunteers: 616.155.294-615.038

Clinical cases

Vladimir Yu. Zorenko

97-102

Experience with efmoroctocog alfa during musculoskeletal surgery in patients with severe hemophilia A: 615.273.52:616.72-007.248

Anastasiya A. Koroleva, Tatyana Yu. Polyanskaya, Dmitry E. Vybornykh, Vladimir Yu. Zorenko

103-109

Victim behavior in hemophilia patients: 616.151.514-056.7:616-005.1